Tenecteplase for stroke after 4.5 hours
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a clot-dissolving medicine called tenecteplase for people who had a stroke more than 4.5 hours ago. It may help you recover if given later than usual.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an ischemic stroke (a clot blocking blood flow in the brain) more than 4.5 hours ago.
- You were able to do most daily activities without help before the stroke (able to walk, dress, bathe alone).
- You are not scheduled for a clot-removal procedure (thrombectomy) at the same hospital right now.
- You do not have bleeding in the brain or a complete blockage of the main neck artery.
- Your stroke symptoms are not too mild or too severe (score between 5 and 25 on a stroke scale).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a clot-busting drug called tenecteplase for people who had a stroke affecting the back part of the brain (posterior circulation). It may be an option if you can get treatment between 4.5 and 24 hours after symptoms started.
This trial studies the use of a clot-busting medicine called tenecteplase given more than 4.5 hours after a stroke starts. It aims to see if this treatment can help people who wake up with stroke symptoms or whose stroke time is unknown.
This trial tests whether a clot-dissolving drug called tenecteplase can improve recovery for people who had a large-vessel ischemic stroke 4.5 to 24 hours earlier and can’t have a mechanical clot removal procedure in time. If you join, you’ll get either tenecteplase or standard medical care, and the study will track your recovery and safety.
This trial tests a new medication called rhTNK-tPA for treating acute ischemic stroke (a clot in the brain) up to 24 hours after symptom onset. The study uses simplified imaging to determine eligibility and aims to help patients recover better outcomes.
This trial tests a clot-busting drug for people who had a stroke but don't know when it started, like waking up with symptoms. It may help reduce disability if given soon after noticing symptoms.
This trial tests a clot-busting drug called tenecteplase given later than usual (4.5 to 9 hours after stroke symptoms) to people whose MRI shows the stroke may still be reversible. The goal is to see if it helps reduce disability after a stroke.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.